Please Wait.....
Report
Enzyme Replacement Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Enzyme Type (Alglucosidase Alfa, Agalsidase Beta, Imiglucerase, Idursulfase, Galsulfase, Velaglucerase Alfa, and Other Enzymes), Therapeutic Conditions (Gaucher's Disease, Fabry's Disease, MPS, Pompe's Disease, SCID, and Other Therapeutic Conditions), Route of Administration (Parenteral and Oral), and End User (Hospitals, Infusion Centers, and Others)
Market Report I 2022-07-18 I 226 Pages I The Insight Partners
The enzyme replacement therapy market is expected to grow from US$ 9,673.39 million in 2021 to US$ 15,184.70 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2022 to 2028.
The report highlights trends prevailing in the market and factors driving the market growth. The growth of the global enzyme replacement therapy market is attributed to the rising prevalence of lysosomal storage diseases (LSDs) and rapid regulatory approval with other marketing benefits for drug with orphan drug designation. However, cutthroat competition among market players hinders the overall market growth.
Enzyme replacement therapy (ERT) is performed to treat congenital enzyme deficiencies by using enzyme or protein having enzymatic activity. Animal, human, and recombinant engineered enzymes are a few sources of enzyme required for treatment. The therapy is generally applied in rare and lysosomal storage diseases, including Pompe's disease, Fabry's disease, Gaucher's disease, Tay-Sachs disease, and Hurler syndrome. The most common ERT method is IV infusions, in which the replacement enzyme is administered directly into the bloodstream through a controlled drip of fluids.
European Medicines Agency (EMA) approves orphan drugs. For instance, according to EMA, if a product that has an orphan drug designation receives EMA marketing approval for the indication for which it has such designation, the product is entitled to orphan market exclusivity. It means the EMA may not approve any other application to market a similar drug for the same indication for 10 years.
Furthermore, in March 2016, the EMA launched the Priority Medicines ("PRIME") scheme to facilitate the development of product candidates in indications, often rare, for which few or no therapies currently exist. The PRIME scheme also provides several benefits to drug producers; once a candidate medicine is selected for PRIME. Below mentioned are the benefits provided by the EMA:
- Appoint a rapporteur from the Committee for Medicinal Products for Human Use (CHMP) and help to build knowledge ahead of a marketing-authorization application
- Early and proactive regulatory dialogue with the EMA to guide the overall development plan and regulatory strategy;
- Provide scientific advice at key development milestones, involving additional stakeholders such as health-technology-assessment bodies, to facilitate quicker access for patients to the new medicine;
- Confirm potential for accelerated assessment at the time of an application for marketing authorization.
Therefore, owing to the benefit and incentives associated with drugs designated as orphan drugs, key players operating in the market are putting efforts into developing drugs for orphan diseases. For instance, Amicus Therapeutics, Inc. recently obtained an orphan medicinal product designation in Europe from the EMA for Galafold to treat Fabry disease and the combination product, ATB200/AT2221, for treating Pompe disease. Additionally, in September 2020, Amicus Therapeutics, Inc. was granted PRIME designation for AT-GTX-501, therapy for CLN6 Batten disease.
Thus, the rapid regulatory approval with other marketing benefits for the drug with orphan drug designation is driving the market growth.
Based on enzyme type, the global enzyme replacement therapy market is segmented into alglucosidase alfa, agalsidase beta, imiglucerase, idursulfase, galsulfase, velaglucerase alfa, and other enzymes. In 2021, the other enzymes segment accounted for the largest market share. The same segment is expected to register the highest CAGR in the market from 2022 to 2028. Based on therapeutic conditions, the global enzyme replacement therapy market is segmented into Gaucher's disease, Fabry's disease, Pompe's disease, SCID, MPS, and other therapeutic conditions. The Gaucher's disease segment held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period. Based on route of administration, the global enzyme replacement therapy market is bifurcated into parenteral and oral. The parenteral segment held a larger market share in 2021 and is anticipated to register a higher CAGR during the forecast period. Based on end user, the global enzyme replacement therapy market is segmented into hospitals, infusion centers, and others. The hospitals segment held the largest market share in 2021. However, the infusion centers segment is expected to register the highest CAGR during the forecast period.
Impact of COVID-19 Pandemic on Global Enzyme Replacement Therapy Market
The COVID-19 pandemic significantly affected the global healthcare system. To combat the spread of SAR-CoV-2 virus, governments imposed stringent policies to prevent and reduce the infection and mortality rates. According to the Department of Emergency Medicine, in many cities across various countries in North America, emergency department (ED) visits decreased by ~40% in 2020. Moreover, outpatient appointments and elective treatments were postponed or replaced by telemedicine practices.
Moreover, the interruption of ERT during the COVID-19 pandemic may have significant consequences. Due to restrictions on hospital visits during the pandemic, many scheduled ERTs were disrupted, which led to severity of conditions in LSDs patients. Also, lysosomal storage diseases are considered to be high risk because of respiratory, renal, and cardiac involvement. For instance, in 2021, a sample survey conducted by some doctors from Sir Ganga Ram Hospital, India, results of which were published in Indian Pediatrics, offered a glimpse into the crisis. The survey revealed that of the 26 patients suffering from lysosomal storage disorders and receiving ERT at the hospital, 20 (77%) had significant interruption in their treatment, with an average eight missed doses. Of the 20 patients who missed multiple doses, 13 (65%) could not collect the medicine from the tertiary care center due to lack of transportation as lockdown was in place, while for two (10%), the medicine import was delayed. Thus, such interruptions in ERT increased the suffering of LSDs patients and impacted the enzyme replacement therapy market negatively.
Various organic and inorganic strategies are adopted by companies operating in the global enzyme replacement therapy market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players in strengthening their customer base and expanding their product portfolios. A few of the significant developments by key players in the global enzyme replacement therapy market are listed below.
- In May 2022, AbbVie and Cugene Inc., a clinical-stage biotechnology company focused on developing next-generation precision immunology and oncology medicines to treat autoimmune disease and cancer, announced an exclusive worldwide license option agreement for CUG252, a potential best-in-class Treg-selective IL-2 mutein, as well as other novel IL-2 muteins, for the potential treatment of autoimmune and inflammatory diseases.
- In August 2021, the US Food and Drug Administration (FDA) approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients aged one year and above suffering from late-onset Pompe disease, a progressive and debilitating muscle disorder that impairs a person's ability to move and breathe. Nexviazyme is an ERT designed to specifically target the mannose-6-phosphate (M6P) receptor, the key pathway for cellular uptake of ERT in Pompe disease. Nexviazyme has been shown in clinical trials to provide patients with improvements in respiratory function and walking distance.
A few major primary and secondary sources referred to while preparing the report on the global enzyme replacement therapy market are the National Health and Medical Research Council (NHMRC), the Government of Canada, and the Bioprocessing Technology Institute (BTI).
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Enzyme Replacement Therapy Market - By Enzyme Type
1.3.2 Global Enzyme Replacement Therapy Market - By Therapeutic Conditions
1.3.3 Global Enzyme Replacement Therapy Market - By Route of Administration
1.3.4 Global Enzyme Replacement Therapy Market - By End User
1.3.5 Global Enzyme Replacement Therapy Market - By Geography
2. Enzyme Replacement Therapy Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Enzyme Replacement Therapy Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa - PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
5. Enzyme Replacement Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Lysosomal Storage Diseases (LSDs)
5.1.2 Rapid Regulatory Approval with Other Benefits for Drug with Orphan Drug Designation
5.2 Market Restraints
5.2.1 Cutthroat Competition among Market Players
5.3 Market Opportunities
5.3.1 Increasing Partnerships and Collaborations to Synergize the Business
5.4 Future Trends
5.4.1 Innovative Developments in ERT
5.5 Impact Analysis
6. Enzyme Replacement Therapy Market- Global Analysis
6.1 Global Enzyme Replacement Therapy Market Revenue Forecast and Analysis
6.1.1 Global Enzyme Replacement Therapy Market Revenue Forecast and Analysis
6.1.2 Global Enzyme Replacement Therapy Market - Market Potential Analysis, By Region
6.2 Market Share Analysis of Key Players in Enzyme Replacement Therapy Market
6.2.1 Company Analysis
6.2.2 Growth Strategy Analysis
6.2.3 Performance of Key Players
6.2.3.1 Sanofi S.A.
6.2.3.2 BioMarin Pharmaceutical Inc.
7. Global Enzyme Replacement Therapy Market Revenue and Forecasts To 2028- by Enzyme Type
7.1 Overview
7.2 Global Enzyme Replacement Therapy Market, By Enzyme Type 2021 & 2028 (%)
7.3 Alglucosidase Alfa
7.3.1 Overview
7.3.2 Alglucosidase Alfa Revenue and Forecast to 2028 (US$ Million)
7.4 Agalsidase Beta
7.4.1 Overview
7.4.2 Agalsidase Beta - Revenue and Forecast to 2028 (US$ Million)
7.5 Imiglucerase
7.5.1 Overview
7.5.2 Imigluceras - Revenue and Forecast to 2028 (US$ Million)
7.6 Idursulfase
7.6.1 Overview
7.6.2 Idursulfase - Revenue and Forecast to 2028 (US$ Million)
7.7 Galsulfase
7.7.1 Overview
7.7.2 Galsulfase - Revenue and Forecast to 2028 (US$ Million)
7.8 Velaglucerase Alfa
7.8.1 Overview
7.8.2 Velaglucerase Alfa - Revenue and Forecast to 2028 (US$ Million)
7.9 Other Enzymes
7.9.1 Overview
7.9.2 Other Enzymes - Revenue and Forecast to 2028 (US$ Million)
8. Enzyme Replacement Therapy Market Analysis And Forecasts To 2028 - By Therapeutic Conditions
8.1 Overview
8.2 Global Enzyme Replacement Therapy Market, By Therapeutic Conditions 2021 & 2028 (%)
8.3 Gaucher's Disease
8.3.1 Overview
8.3.2 Gaucher's Disease - Market Revenue and Forecast to 2028 (US$ Million)
8.4 Fabry's Disease
8.4.1 Overview
8.4.2 Fabry's Disease - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Mucopolysaccharidosis (MPS)
8.5.1 Overview
8.5.2 MPS - Market Revenue and Forecast to 2028 (US$ Million)
8.6 Pompe's Disease
8.6.1 Overview
8.6.2 Pompe's Disease - Market Revenue and Forecast to 2028 (US$ Million)
8.7 SCID
8.7.1 Overview
8.7.2 SCID - Market Revenue and Forecast to 2028 (US$ Million)
8.8 Other Therapeutic Conditions
8.8.1 Overview
8.8.2 Other Therapeutic Conditions - Market Revenue and Forecast to 2028 (US$ Million)
9. Enzyme Replacement Therapy Market Analysis And Forecasts To 2028 - By Route of Administration
9.1 Overview
9.2 Global Enzyme Replacement Therapy Market, By Route of Administration 2021 & 2028 (%)
9.3 Parenteral
9.3.1 Overview
9.3.2 Parenteral - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
9.4.1 Overview
9.4.2 Oral - Market Revenue and Forecast to 2028 (US$ Million)
10. Global Enzyme Replacement Therapy Market Analysis- By End User
10.1 Overview
10.2 Global Enzyme Replacement Therapy Market, By End User 2021 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
10.4 Infusion Centers
10.4.1 Overview
10.4.2 Infusion Centers - Market Revenue And Forecasts To 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others - Market Revenue And Forecasts To 2028 (US$ Million)
11. Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 - Geographical Analysis
11.1 North America: Enzyme Replacement Therapy Market
11.1.1 Overview
11.1.2 North America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.1.4 North America: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.1.5 North America: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.1.6 North America: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.1.7 North America: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 US: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.1.7.1.4 US: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.1.7.1.5 US: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.1.7.1.6 US: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.1.7.2 Canada: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Canada: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.1.7.2.4 Canada: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.1.7.2.5 Canada: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.1.7.2.6 Canada: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.1.7.3 Mexico: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 Mexico: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.1.7.3.4 Mexico: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.1.7.3.5 Mexico: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.1.7.3.6 Mexico: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.2 Europe: Enzyme Replacement Therapy Market
11.2.1 Overview
11.2.2 Europe: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.2.4 Europe: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.2.5 Europe: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.2.6 Europe: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.2.7 Europe: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)
11.2.7.1 Germany: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.3 Germany: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.2.7.1.4 Germany: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.2.7.1.5 Germany: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.2.7.1.6 Germany: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.2.7.2 UK: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 UK: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.3 UK: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.2.7.2.4 UK: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.2.7.2.5 UK: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.2.7.2.6 UK: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.2.7.3 France: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 France: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.3 France: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.2.7.3.4 France: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.2.7.3.5 France: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.2.7.3.6 France: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.2.7.4 Italy: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.3 Italy: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.2.7.4.4 Italy: Enzyme Replacem4ent Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.2.7.4.5 Italy: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.2.7.4.6 Italy: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.2.7.5 Spain: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.3 Spain: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.2.7.5.4 Spain: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.2.7.5.5 Spain: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.2.7.5.6 Spain: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.2.7.6 Rest of Europe: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
11.2.7.6.6 Rest of Europe: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.3 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts To 2028
11.3.1 Overview
11.3.2 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.3 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.3.4 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.3.5 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.3.6 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Country (%)
11.3.7.1 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.3 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.3.7.1.4 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.3.7.1.5 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.3.7.1.6 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.2 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.3 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.3.7.2.4 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.3.7.2.5 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.3.7.2.6 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.3 India Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.3 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.3.7.3.4 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.3.7.3.5 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.3.7.3.6 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.4 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.3 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.3.7.4.4 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.3.7.4.5 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.3.7.4.6 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.5 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.3 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.3.7.5.4 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.3.7.5.5 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.3.7.5.6 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.6 Rest of Asia Pacific: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.4 South & Central America: Enzyme Replacement Therapy Market
11.4.1 Overview
11.4.2 South and Central America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.4.3 South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (USD Million)
11.4.4 South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (USD Million)
11.4.5 South and Central America: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (USD Million)
11.4.6 South and Central America: Enzyme Replacement Therapy Market, by End User, 2019-2028 (USD Million)
11.4.7 South and Central America: Enzyme Replacement Therapy Market, by country, 2021 & 2028 (%)
11.4.7.1 Brazil: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.1 Brazil: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.2 Brazil: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (USD Million)
11.4.7.1.3 Brazil: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (USD Million)
11.4.7.1.4 Brazil: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (USD Million)
11.4.7.1.5 Brazil: Enzyme Replacement Therapy Market, by End User, 2019-2028 (USD Million)
11.4.7.2 Argentina: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.2.1 Argentina: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.2.2 Argentina: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (USD Million)
11.4.7.2.3 Argentina: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (USD Million)
11.4.7.2.4 Argentina: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (USD Million)
11.4.7.2.5 Argentina: Enzyme Replacement Therapy Market, by End User, 2019-2028 (USD Million)
11.4.7.3 Rest of South and Central America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.3.1 Rest of South and Central America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.3.2 Rest of South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (USD Million)
11.4.7.3.3 Rest of South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (USD Million)
11.4.7.3.4 Rest of South and Central America: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (USD Million)
11.4.7.3.5 Rest of South and Central America: Enzyme Replacement Therapy Market, by End User, 2019-2028 (USD Million)
11.5 Middle East & Africa Enzyme Replacement Therapy Market
11.5.1 Overview
11.5.2 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
11.5.3 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Enzyme Type (US$ Million)
11.5.4 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Therapeutic Conditions (US$ Million)
11.5.5 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Route of Administration (US$ Million)
11.5.6 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by End User (US$ Million)
11.5.7 Middle East & Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Country (%)
11.5.7.1 Saudi Arabia: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Overview
11.5.7.1.2 Saudi Arabia Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.3 Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
11.5.7.1.4 Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)
11.5.7.1.5 Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
11.5.7.1.6 Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)
11.5.7.2 South Africa: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Overview
11.5.7.2.2 South Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.3 South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
11.5.7.2.4 South Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)
11.5.7.2.5 South Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Route of Administration (US$ Million)
11.5.7.2.6 South Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)
11.5.7.3 UAE: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Overview
11.5.7.3.2 UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.3 UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
11.5.7.3.4 UAE: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)
11.5.7.3.5 UAE: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Route of Administration (US$ Million)
11.5.7.3.6 UAE: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)
11.5.7.4 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.4.1 Overview
11.5.7.4.2 Rest of the Middle East and Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
11.5.7.4.3 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
11.5.7.4.4 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)
11.5.7.4.5 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Route of Administration (US$ Million)
11.5.7.4.6 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)
12. Impact Of COVID-19 Pandemic on Enzyme Replacement Therapy Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 South and Central America: Impact Assessment of COVID-19 Pandemic
12.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13. Enzyme Replacement Therapy Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Enzyme Replacement Therapy Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Takeda Pharmaceutical Company Limited
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 inancial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sanofi
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 AbbVie Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 BioMarin Pharmaceutical Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Amicus Therapeutics
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Alexion Pharmaceuticals, Inc.(AstraZeneca)
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 WOT Analysis
14.6.6 Key Developments
14.7 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Recordati S.p.A.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Pfizer Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 CHIESI Farmaceutici S.p.A.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 3. North America Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 4. North America Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 5. US: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 7. US Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 8. US Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 19. Europe Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 20. Europe Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 21. Germany Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 23. Germany Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 24. Germany Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 25. UK Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 26. UK Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 27. UK Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 28. UK Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 29. France Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 30. France Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 31. France Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 32. France Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 33. Italy Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 35. Italy Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 36. Italy Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 37. Spain Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 39. Spain Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 40. Spain Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 43. Rest of Europe Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 44. Rest of Europe Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 45. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million).
Table 46. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 47. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 48. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 49. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 50. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 51. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 52. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 53. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 54. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 55. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 56. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 57. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 58. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 59. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 60. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 61. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 62. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 63. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 64. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 65. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 66. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 67. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 68. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 69. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 70. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 71. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 72. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 73. South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (USD Million)
Table 74. South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 75. South and Central America: Enzyme Replacement Therapy Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 76. South and Central America: Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 77. Brazil: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (USD Million)
Table 78. Brazil: Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 79. Brazil: Enzyme Replacement Therapy Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 80. Brazil: Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 81. Argentina: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (USD Million)
Table 82. Argentina: Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 83. Argentina: Enzyme Replacement Therapy Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 84. Argentina: Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 85. Rest of South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of South and Central America: Enzyme Replacement Therapy Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of South and Central America: Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 89. Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Enzyme Type (US$ Million)
Table 90. Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Therapeutic Conditions (US$ Million)
Table 91. Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Route of Administration (US$ Million)
Table 92. Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 93. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
Table 94. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)
Table 95. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 96. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 97. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
Table 98. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)
Table 99. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 100. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 101. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
Table 102. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)
Table 103. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 104. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 105. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
Table 106. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)
Table 107. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 108. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 109. Recent Inorganic Growth Strategies in the Enzyme Replacement Therapy Market
Table 110. Recent Organic Growth Strategies in the Enzyme Replacement Therapy Market
Table 111. Glossary of Terms
LIST OF FIGURES
Figure 1. Enzyme Replacement Therapy Market Segmentation
Figure 2. Enzyme Replacement Therapy Market Segmentation, By Region
Figure 3. Global Enzyme Replacement Therapy Market Overview
Figure 4. Others Enzyme Segment Held Largest Share by Enzyme Type in Enzyme Replacement Therapy Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Enzyme Replacement Therapy Market, By Geography (US$ Million)
Figure 7. Global Enzyme Replacement Therapy Market - Leading Country Markets (US$ Million)
Figure 8. Global Enzyme Replacement Therapy Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Impact Analysis
Figure 15. Global Enzyme Replacement Therapy Market- Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Enzyme Replacement Therapy Market- Revenue Forecast And Analysis - 2021 - 2028
Figure 17. Global Enzyme Replacement Therapy Market - Market Potential Analysis, By Region
Figure 18. Market Share Analysis of Key Players in Global Enzyme Replacement Therapy Market
Figure 19. Global Enzyme Replacement Therapy Market - Comparative Company Analysis
Figure 20. Global Enzyme Replacement Therapy Market - Growth Strategy Analysis
Figure 21. Market positioning of Key Players in Enzyme Replacement Therapy Market
Figure 22. Global Enzyme Replacement Therapy Market, by Enzyme Type 2021 & 2028 (%)
Figure 23. Alglucosidase Alfa Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Agalsidase Beta - Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Imiglucerase - Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Idursulfase - Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Galsulfase - Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Velaglucerase Alfa - Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Other Enzymes - Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Global Enzyme Replacement Therapy Market, by Therapeutic Conditions 2021 & 2028 (%)
Figure 31. Gaucher's Disease - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Fabry's Disease - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. MPS - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Pompe's Disease - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. SCID - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Other Therapeutic Conditions - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Global Enzyme Replacement Therapy Market, by Route of Administration 2021 & 2028 (%)
Figure 38. Parenteral - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Oral - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. Global Enzyme Replacement Therapy Market, by End User 2021 & 2028 (%)
Figure 41. Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 42. Infusion Centers - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 43. Others- Market Revenue And Forecasts To 2028 (US$ Million)
Figure 44. North America: Enzyme Replacement Therapy Market, by Key Country - Revenue (2021) (US$ Million)
Figure 45. North America Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. North America: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)
Figure 47. US: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Canada: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Mexico: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Europe: Enzyme Replacement Therapy Market, by Key Country - Revenue (2021) (US$ Million)
Figure 51. Europe: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 52. Europe: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)
Figure 53. Germany: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. UK: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. France: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Italy: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. Spain: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 58. Rest of Europe: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. Asia Pacific: Enzyme Replacement Therapy Market Overview, by Country (2021)
Figure 60. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Country (%)
Figure 62. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 63. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 64. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 65. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 66. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. Rest of Asia Pacific: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. South and Central America: Enzyme Replacement Therapy Market, by Key Country - Revenue (2021) (US$' Million)
Figure 69. South and Central America Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (USD Million)
Figure 70. South and Central America: Enzyme Replacement Therapy Market, by country, 2021 & 2028 (%)
Figure 71. Brazil: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
Figure 72. Argentina: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
Figure 73. Rest of South and Central America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
Figure 74. Middle East & Africa Enzyme Replacement Therapy Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 75. Middle East & Africa Enzyme: Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 76. Middle East & Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Country (%)
Figure 77. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 78. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 79. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 80. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 81. Impact of COVID-19 Pandemic in North American Country Markets
Figure 82. Impact of COVID-19 Pandemic in European Country Markets
Figure 83. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 84. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 85. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 86. Growth Strategies in the Enzyme Replacement Therapy Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security